Daniela Bischof is an Assistant Professor of Clinical Medical and Molecular Genetics, and Director of Vector Production (Cell and Gene Therapy Manufacturing) at the Indiana University School of Medicine. She has almost 20 years of experience in the field of gene therapy, starting with Adeno-Associated Viruses (AAV) in late 2002 and moving on to lentiviruses and retroviruses in 2007.
In 1997 Dr Bischof obtained her PhD from the University of the Witwatersrand in South Africa in the field of Experimental Oncology (work performed at St. Jude Children’s Research Hospital in Memphis, Tennessee). She then acquired 3 years of experience in B-cell biology at the Mayo Clinic in Rochester, Minnesota. Dr Bischof joined the Indiana University School of Medicine in 2002. She has been involved in the production of clinical grade gene therapy lentiviral and retroviral products since 2007. She is responsible for orchestrating the manufacturing of these products and ensuring they meet FDA standards, prior to delivery to academic and commercial customers within the United States and internationally.